Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of NO Donor Therapy on the Dystrophic Mouse Quadricep Metabolome (part VIII)

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Heart

DISEASE(S): Muscular Dystrophy

PROVIDER: ST000652 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Effects of NO Donor Therapy on the Dystrophic Mouse Heart Metabolome (part VII)

Project description: Not available

| ST000651 | MetabolomicsWorkbench

Effects of NO Donor Therapy on the Dystrophic Mouse Muscle TCA Cycle (part VI)

Project description: Not available

| ST000650 | MetabolomicsWorkbench

Effects of NO Donor Therapy on the Dystrophic Mouse Muscle Amino Acids (part IV)

Project description: Not available

| ST000648 | MetabolomicsWorkbench

Mouse models of non-dystrophic and dystrophic myotonia exhibit nociplastic pain-like behaviors.

Project description: Not available

| S-EPMC11212949 | biostudies-literature

Methyl-Donor Micronutrient for Gestating Sows: Effects on Gut Microbiota and Metabolome in Offspring Piglets.

Project description: Not available

| S-EPMC8215270 | biostudies-literature

Effects of carbonic anhydrase VIII deficiency on cerebellar gene expression profiles in the wdl mouse.

Project description: Not available

| S-EPMC1865515 | biostudies-literature

Differential analysis of dystrophic dog muscle after MuStem cell therapy

Project description:Duchenne Muscular Dystrophy (DMD), the most common form of inherited neuromuscular disorder, is caused by mutations in the dystrophin gene leading to progressive muscle loss. Secondary changes in signaling pathways and energy metabolism are aggravating factors. Thus, for the evaluation of novel therapeutic approaches, it is essential to analyse the reversal of both primary and secondary abnormalities in treated muscle. MuStem cells constitute a new progenitor cell population proposed as a source of cells for a therapeutic strategy. When injected in Golden Retriever Muscular Dystrophy (GRMD) dogs, MuStem cells contribute to myofiber regeneration, satellite cell replenishment, and dystrophin expression. This cell therapy leads to muscle damage course limitation with an increased regeneration activity and an interstitial expansion restriction, and persisting stabilization of the dog's clinical status. In this study, we used isotope-coded protein labeling (ICPL) to compare the protein expression profiles of muscles coming from three different types of dogs: healthy, GRMD and GRMD after injection of MuStem cells. Based on the comparison of three biological replicates, these triplex ICPL experiments led to the identification of proteins differentially expressed after treatment. This study contributes to a better understanding of the mechanisms of action of MuStem cells.

2019-05-24 | PXD001768 | Pride

Parental Effects on Seed Transcriptome-Metabolome

Project description:Transcriptome analyses on seeds developed in different parental conditions investigating the effect of the parental environment on the transcriptome of dry seeds of three different genotypes RNA isolated from freshly harvested dry seed of three genotypes, the near isogenic line of DELAY OF GEMRMINATION 1 (DOG1), DOG3 and DOG6, grown in 15Â°C, 20Â°, low nitrate (N0), low light (LL) and SL (standard light). Please note that SL (standard light) is the control for the LL (low light), and 20C is the control for both 15C and low nitrate (N0).

2016-07-03 | E-GEOD-75837 | biostudies-arrayexpress

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.

Project description: Not available

| S-EPMC2276400 | biostudies-literature

Immunoproteasome Inhibition Ameliorates Aged Dystrophic Mouse Muscle Environment.

Project description: Not available

| S-EPMC9739773 | biostudies-literature